Patents by Inventor Xiaotong HU

Xiaotong HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • and application of compound bacterium preparation prepared from in preparing medicine for treating or preventing avian influenza virus infection
    Patent number: 11786566
    Abstract: Bifidobacterium animalis and application of a compound bacterium preparation prepared from the Bifidobacterium animalis in the preparation of a medicine for treating or preventing avian influenza virus infection. The invention discovers that Bifidobacterium animalis ATCC Accession No. 25527 can be used for treating animals infected by H7N9, and after the Bifidobacterium animalis ATCC Accession No. 25527 is compounded with Bifidobacterium pseudolongum ATCC Accession No. 25526, the effect is better. The compound preparation can regulate the body immune response, remarkably improve the weight loss and lung tissue injury caused by H7N9 influenza virus infection, and obviously improve the survival rate of mice infected by H7N9 influenza virus. The compound probiotic preparation provided by the invention has a remarkable effect of resisting H7N9 influenza virus infection, and can be effectively used for preventing and treating avian influenza virus infection.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: October 17, 2023
    Assignee: Huazhong Agricultural University
    Inventors: Meilin Jin, Qiang Zhang, Xiaotong Hu, Li Yang, Jin Hu, Ting Wang, Xiaomei Sun, Zhong Zou, Wenxiao Gong, Xian Lin
  • Application of valine in preparing medicine for treating or preventing avian influenza virus infection
    Patent number: 11717503
    Abstract: Application of valine in the preparation of a medicine for treating or preventing avian influenza virus infection. In a lethal mouse influenza infection model, the use of valine to treat infected mice can effectively improve the weight loss of mice, increase the survival rate of mice, and can effectively reduce the virus titer in the supernatant of the lung tissue of the infected mice.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: August 8, 2023
    Assignee: Huazhong Agricultural University
    Inventors: Meilin Jin, Qiang Zhang, Xiaotong Hu, Li Yang, Ting Wang, Xiaomei Sun, Chao Kang, Ming Zhong
  • APPLICATION OF VALINE IN PREPARING MEDICINE FOR TREATING OR PREVENTING AVIAN INFLUENZA VIRUS INFECTION
    Publication number: 20210220311
    Abstract: Application of valine in the preparation of a medicine for treating or preventing avian influenza virus infection. In a lethal mouse influenza infection model, the use of valine to treat infected mice can effectively improve the weight loss of mice, increase the survival rate of mice, and can effectively reduce the virus titer in the supernatant of the lung tissue of the infected mice.
    Type: Application
    Filed: January 11, 2021
    Publication date: July 22, 2021
    Inventors: Meilin JIN, Qiang ZHANG, Xiaotong HU, Li YANG, Ting WANG, Xiaomei SUN, Chao KANG, Ming ZHONG
  • BIFIDOBACTERIUM ANIMALIS AND APPLICATION OF COMPOUND BACTERIUM PREPARATION PREPARED FROM BIFIDOBACTERIUM ANIMALIS IN PREPARING MEDICINE FOR TREATING OR PREVENTING AVIAN INFLUENZA VIRUS INFECTION
    Publication number: 20210213075
    Abstract: Bifidobacterium animalis and application of a compound bacterium preparation prepared from the Bifidobacterium animalis in the preparation of a medicine for treating or preventing avian influenza virus infection. The invention discovers that Bifidobacterium animalis ATCC Accession No. 25527 can be used for treating animals infected by H7N9, and after the Bifidobacterium animalis ATCC Accession No. 25527 is compounded with Bifidobacterium pseudolongum ATCC Accession No. 25526, the effect is better. The compound preparation can regulate the body immune response, remarkably improve the weight loss and lung tissue injury caused by H7N9 influenza virus infection, and obviously improve the survival rate of mice infected by H7N9 influenza virus. The compound probiotic preparation provided by the invention has a remarkable effect of resisting H7N9 influenza virus infection, and can be effectively used for preventing and treating avian influenza virus infection.
    Type: Application
    Filed: January 4, 2021
    Publication date: July 15, 2021
    Inventors: Meilin JIN, Qiang ZHANG, Xiaotong HU, Li YANG, Jin HU, Ting WANG, Xiaomei SUN, Zhong ZOU, Wenxiao GONG, Xian LIN